85 related articles for article (PubMed ID: 19915944)
1. Raised concentration of soluble form of vascular endothelial cadherin and IL-23 in sera of patients with Behçet's disease.
Habibagahi Z; Habibagahi M; Heidari M
Mod Rheumatol; 2010 Apr; 20(2):154-9. PubMed ID: 19915944
[TBL] [Abstract][Full Text] [Related]
2. Increased serum soluble vascular endothelial cadherin levels in patients with chronic spontaneous urticaria.
Chen T; Guo ZP; Wang WJ; Fu LX; Sun QM; Zhou PM
Ann Allergy Asthma Immunol; 2017 Jun; 118(6):704-709. PubMed ID: 28583263
[TBL] [Abstract][Full Text] [Related]
3. Increased serum levels of soluble vascular endothelial-cadherin in patients with systemic vasculitis.
Chen T; Guo ZP; Cao N; Qin S; Li MM; Jia RZ
Rheumatol Int; 2014 Aug; 34(8):1139-43. PubMed ID: 24469639
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial cadherin shedding is more severe in sepsis patients with severe acute kidney injury.
Yu WK; McNeil JB; Wickersham NE; Shaver CM; Bastarache JA; Ware LB
Crit Care; 2019 Jan; 23(1):18. PubMed ID: 30658667
[TBL] [Abstract][Full Text] [Related]
5. Soluble Vascular Endothelial Cadherin as a New Biomarker of Irradiation in Highly Irradiated Baboons with Bone Marrow Protection.
Hérodin F; Voir D; Vilgrain I; Courçon M; Drouet M; Boittin FX
Health Phys; 2016 Jun; 110(6):598-605. PubMed ID: 27115227
[TBL] [Abstract][Full Text] [Related]
6. sVE-cadherin and sCD146 serum levels in patients with multiple myeloma.
Wrobel T; Mazur G; Wolowiec D; Jazwiec B; Sowinska E; Kuliczkowski K
Clin Lab Haematol; 2006 Feb; 28(1):36-9. PubMed ID: 16430458
[TBL] [Abstract][Full Text] [Related]
7. Soluble vascular endothelial-cadherin levels correlate with clinical and biological aspects of severe ovarian hyperstimulation syndrome.
Villasante A; Pacheco A; Pau E; Ruiz A; Pellicer A; Garcia-Velasco JA
Hum Reprod; 2008 Mar; 23(3):662-7. PubMed ID: 18216038
[TBL] [Abstract][Full Text] [Related]
8. Correlation between IL-17A/F, IL-23, IL-35 and IL-12/-23 (p40) levels in peripheral blood lymphocyte cultures and disease activity in Behcet's patients.
Sonmez C; Yucel AA; Yesil TH; Kucuk H; Sezgin B; Mercan R; Yucel AE; Demirel GY
Clin Rheumatol; 2018 Oct; 37(10):2797-2804. PubMed ID: 29557072
[TBL] [Abstract][Full Text] [Related]
9. Investigating the role of IL-33 in the pathogenesis of Behçet's Disease.
Çerçi P; Altıner S; İnal A; Köse K; Keskin G; Ölmez Ü
Acta Clin Belg; 2017 Dec; 72(6):434-438. PubMed ID: 28412856
[TBL] [Abstract][Full Text] [Related]
10. Levels of soluble E-selectin in patients with active Behcet's disease.
Sari RA; Kiziltunç A; Taysi S; Akdemir S; Gündoğdu M
Clin Rheumatol; 2005 Feb; 24(1):55-9. PubMed ID: 15338451
[TBL] [Abstract][Full Text] [Related]
11. Serum angiostatin levels in patients with Behçet's disease: does angiogenesis play a role in the pathogenesis of Behçet's disease?
Keskin D; Keskin G; Inal A; Ozışık L
Acta Clin Belg; 2014 Aug; 69(4):246-50. PubMed ID: 25012748
[TBL] [Abstract][Full Text] [Related]
12. Soluble vascular endothelial-cadherin levels in patients with sepsis treated with direct hemoperfusion with a polymyxin B-immobilized fiber column.
Ebihara I; Hirayama K; Nagai M; Koda M; Gunji M; Okubo Y; Katayama T; Sato C; Usui J; Yamagata K; Kobayashi M
Ther Apher Dial; 2014 Jun; 18(3):272-8. PubMed ID: 24965294
[TBL] [Abstract][Full Text] [Related]
13. Plasma sE-cadherin and the plasma sE-cadherin/sVE-cadherin ratio are potential biomarkers for chronic obstructive pulmonary disease.
Shirahata T; Nakamura H; Nakajima T; Nakamura M; Chubachi S; Yoshida S; Tsuduki K; Mashimo S; Takahashi S; Minematsu N; Tateno H; Asano K; Fujishima S; Betsuyaku T
Biomarkers; 2018 Jul; 23(5):414-421. PubMed ID: 29376431
[TBL] [Abstract][Full Text] [Related]
14. The relationship of serum VEGF and sVEGFR-1 levels with vascular involvement in patients with Behçet's disease.
Sertoglu E; Omma A; Yucel C; Colak S; Sandıkcı SC; Ozgurtas T
Scand J Clin Lab Invest; 2018 Oct; 78(6):443-449. PubMed ID: 30015524
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet's disease.
Lew W; Chang JY; Jung JY; Bang D
Br J Dermatol; 2008 Mar; 158(3):505-11. PubMed ID: 18205865
[TBL] [Abstract][Full Text] [Related]
16. Increased serum levels of interleukin-8 in polyarteritis nodosa and Behçet's disease.
Freire Ade L; Bertolo MB; de Pinho AJ; Samara AM; Fernandes SR
Clin Rheumatol; 2004 Jun; 23(3):203-5. PubMed ID: 15168145
[TBL] [Abstract][Full Text] [Related]
17. IL-38 serum levels in patients with Behcet's disease and the relationship with clinical features.
Zarrabi M; Gholijani N; Shenavandeh S; Aflaki E; Amirghofran Z
Eur Cytokine Netw; 2019 Sep; 30(3):82-87. PubMed ID: 31957702
[TBL] [Abstract][Full Text] [Related]
18. Immunometabolic biomarkers of inflammation in Behçet's disease: relationship with epidemiological profile, disease activity and therapeutic regimens.
Cantarini L; Pucino V; Vitale A; Talarico R; Lucherini OM; Magnotti F; De Rosa V; Galgani M; Alviggi C; Marone G; Galeazzi M; Matarese G
Clin Exp Immunol; 2016 May; 184(2):197-207. PubMed ID: 26756979
[TBL] [Abstract][Full Text] [Related]
19. Increased levels of soluble vascular endothelial cadherin are associated with poor outcome in severe sepsis.
Zhang RY; Liu YY; Li L; Cui W; Zhao KJ; Huang WC; Gu XW; Liu W; Wu J; Min D; Mao EQ; Tang YQ
J Int Med Res; 2010; 38(4):1497-506. PubMed ID: 20926024
[TBL] [Abstract][Full Text] [Related]
20. Serum galectin-3 levels in patients with Behçet's disease: association with disease activity over a long-term follow-up.
Özden MG; Caycı YT; Tekin H; Çoban AY; Aydın F; Sentürk N; Bek Y; Cantürk T; Turanlı AY
J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1168-73. PubMed ID: 21214630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
